Technegas’ new use in lung transplant imaging

Radiopharmaceutical medical imaging manufacturer Cyclopharm has revealed a possible new use for its Technegas system – for evaluating the progress of lung transplantation. The use is detailed in a US-based study which highlights the clinical utility and operational benefits of the Technegas technology compared to current US ventilation imaging radiopharmaceuticals used in lung transplant evaluation.…

Cyclopharm makes first sale to giant US healthcare system

Radiopharmaceutical medical imaging company Cyclopharm has received its first purchase orders from two United States Veterans Health Administration (VA) Hospitals – part of the largest integrated US Government health care system in the United States (US). The purchase orders for an initial five-year term apply to the installation and annual charges associated with the Technegas…

Optiscan to develop AI gastrointestinal endomicroscope

Optiscan Imaging and Monash University have agreed to work together on its its project to develop the next-gen gastrointestinal (GI) flexible endomicroscope and Edge-AI-enabled technology. The agreement represents a further extension of the longstanding relationship Optiscan has with Monash University, with the company’s technology originally created at the university. AI capabilities are critical to Optiscan’s…

Micro-X licensing, sales and R&D progress

Carbon fibre nanotube X-ray manufacturer Micro-X made significant progress in the quarter to September as it commercialises its unique technology through increased sales activity, funded R&D activities and technology licensing to non competing firms. During the Quarter the company successfully completed the technology transfer to medical X-ray tube to Varex Imaging Corporation for NEX Technology…

EMVision’s positive results in stroke detection

Medical imaging manufacturer EMVision Medical Devices has reported positive interim analysis from the latest clinical trials of its lightweight stroke imager. The multi-site clinical trials were focused on developing EMVision’s neurodiagnostic AI algorithms to aid in the diagnosis of suspected haemorrhagic or ischaemic stroke. EMVision is one of two Australian companies developing lightweight imaging devices…

Breakthrough Victoria invests in gut gas detection startup

Breakthrough Victoria has announced an investment in Atmo Biosciences, a medical technology company that has developed capsules that are swallowed and electronically diagnose gastrointestinal disorders. Breakthrough Victoria — an independent company set up in 2021 to manage the state government’s $2 billion Breakthrough Victoria Fund — did not disclose the size of the investment. In…